Are you over 18 and want to see adult content?
More Annotations
A complete backup of onlinecasinoslots.icu
Are you over 18 and want to see adult content?
A complete backup of sba-research.org
Are you over 18 and want to see adult content?
A complete backup of supplement4muscle.com
Are you over 18 and want to see adult content?
A complete backup of itunescodesncards.com
Are you over 18 and want to see adult content?
A complete backup of creditchecktotal.com
Are you over 18 and want to see adult content?
A complete backup of sallybeauty.co.uk
Are you over 18 and want to see adult content?
A complete backup of themotionpictureco.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of ketodietecrt.com
Are you over 18 and want to see adult content?
A complete backup of healthimprove.us
Are you over 18 and want to see adult content?
Text
TRIAL
Cancer Center. Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing thediscoveries that
CLINICAL TRIALS RESOURCES FOR HEALTH PROFESSIONALS Budgets and Contracts. The Budgets and Contracts office works in cooperation with principal investigators, industry and non-industry sponsors, and the Office of Contracts Management to develop, negotiate and execute comprehensive and compliant budgets/contracts for all types of clinical trials.PROSTATE CANCER
Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. The prostate is a gland in the male reproductive system.It lies just below the bladder (the organ that collects and empties urine) and in front of the rectum (the lower part of the intestine).It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from theREID
Profile. Sonya Reid, MD, MPH is an Assistant Professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center (Vanderbilt-Ingram Cancer Center). Dr. Reid's research primarily focuses on health disparities in breast cancer, young-onset breast cancer, and hereditary breast cancer. Specifically, she is investigating genomicLOVLY
Associate Professor of Medicine (Hematology/Oncology) Contact. Phone. (615) 936-3457. Email. christine.lovly@vumc.org. (link sends email) Vanderbilt-Ingram Cancer Center. 2220 Pierce Ave South.DAVIS
Dr. Davis is a medical oncologist who specializes in the treatment of patients with bone and soft tissue sarcoma. She received her Bachelor of Science in biology from Duke University and her Doctor of Medicine degree from Wright State University School of Medicine. She then completed her Internal Medicine residency and Hematology-OncologyMANNION
Dr. Mannion cares for patients with benign and malignant tumors of the head and neck, and upper aerodigestive tract. This includes open and endoscopic procedures, as well as minor and major reconstruction of defects after tumor removal.WINKFIELD
Ph.D., Duke University, Pathology. M.D., Duke University, Medicine. Research Emphasis. PublicationsMORGAN
Reddy NM, Greer JP, Morgan DS, Chen H, Park SI, Richards KL.A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma.BARAJAS
VICC Community Outreach and Engagement Office 691 Preston Research Building 2220 Pierce Ave Nashville, TN 37232 HOME | VANDERBILT-INGRAM CANCER CENTERRESEARCHGIVINGCOMMUNITYABOUTCANCER CARE OVERVIEWFIND A CLINICALTRIAL
Cancer Center. Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing thediscoveries that
CLINICAL TRIALS RESOURCES FOR HEALTH PROFESSIONALS Budgets and Contracts. The Budgets and Contracts office works in cooperation with principal investigators, industry and non-industry sponsors, and the Office of Contracts Management to develop, negotiate and execute comprehensive and compliant budgets/contracts for all types of clinical trials.PROSTATE CANCER
Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. The prostate is a gland in the male reproductive system.It lies just below the bladder (the organ that collects and empties urine) and in front of the rectum (the lower part of the intestine).It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from theREID
Profile. Sonya Reid, MD, MPH is an Assistant Professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center (Vanderbilt-Ingram Cancer Center). Dr. Reid's research primarily focuses on health disparities in breast cancer, young-onset breast cancer, and hereditary breast cancer. Specifically, she is investigating genomicLOVLY
Associate Professor of Medicine (Hematology/Oncology) Contact. Phone. (615) 936-3457. Email. christine.lovly@vumc.org. (link sends email) Vanderbilt-Ingram Cancer Center. 2220 Pierce Ave South.DAVIS
Dr. Davis is a medical oncologist who specializes in the treatment of patients with bone and soft tissue sarcoma. She received her Bachelor of Science in biology from Duke University and her Doctor of Medicine degree from Wright State University School of Medicine. She then completed her Internal Medicine residency and Hematology-OncologyMANNION
Dr. Mannion cares for patients with benign and malignant tumors of the head and neck, and upper aerodigestive tract. This includes open and endoscopic procedures, as well as minor and major reconstruction of defects after tumor removal.WINKFIELD
Ph.D., Duke University, Pathology. M.D., Duke University, Medicine. Research Emphasis. PublicationsMORGAN
Reddy NM, Greer JP, Morgan DS, Chen H, Park SI, Richards KL.A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma.BARAJAS
VICC Community Outreach and Engagement Office 691 Preston Research Building 2220 Pierce Ave Nashville, TN 37232CLINICAL TRIALS
Clinical Trials Eligibility. Patients: Submit the Self-Referral Form. (link is external) and a member of our clinical trials team will contact you. If you wish to speak with someone now, please call 1-800-811-8480. Referring Providers: Call our clinical trials team 1-800-811-8480 or submit information about your patient through oursecure
ENG
Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program. She joined the faculty at Vanderbilt-Ingram Cancer Center in July 2019. Her primary clinical research interests include clinical trials involving innovative drugsfor
FLOWCHARTS FOR REFERRING PHYSICIANS Flowcharts for Referring Physicians. The Clinical Trial Flowcharts are "maps" to help you find clinical trials applicable to various types ofcancers. Browse our
GILBERT
Jill Gilbert, M.D. Professor of Medicine (Hematology/Oncology) Director, Hematology/Oncology Fellowship Program. 615-343-4677. jill.gilbert@vumc.org. Vanderbilt University Medical Center. 777 Preston Research Building. 2220 Pierce Avenue. Nashville, TN37232-6307.
GREGOR
Catherine Gregor, M.B.A., is the Director of Clinical Research Administration at the Vanderbilt-Ingram Cancer Center (VICC). In this role, Ms. Gregor leads and manages the cancer center's clinical research portfolio and Clinical Trials Office (CTO) to support the clinical research, operations andMANNION
Dr. Mannion cares for patients with benign and malignant tumors of the head and neck, and upper aerodigestive tract. This includes open and endoscopic procedures, as well as minor and major reconstruction of defects after tumor removal.RICKMAN
Dr. Otis B. Rickman grew up in southeast Oklahoma. After graduation from Hugo High School in 1989 he went on to attend Oklahoma State University where he received a B.S in Biological Sciences in 1993 and then his D.O. degree in 1998. LONG-TERM PROSPECTIVE REGISTRY IN PROSTATE CANCER PATIENTS This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change in treatment, and clinical outcomes. CAI | VANDERBILT-INGRAM CANCER CENTER Vanderbilt University Medical Center Medical Center North B-2104 1161 21st Avenue South Nashville, TN 37232-2400PRESCOTT
Dr. Prescott is a gynecologic oncologist who focuses on the surgical and medical treatment of gynecologic malignancies including ovarian, endometrial, vulva, vaginal and cervix cancers. Skip to main content1-877-936-8422
VICC
Search
MAIN NAVIGATION
* ">Home
* Patient Care
* Cancer Care Overview* Find a Doctor
* Request an Appointment * Find a Clinical Trial * MyHealth at Vanderbilt * Support & Education * Cancer Information* Research
* Research Overview
* Research Programs
* Shared Resources
* Clinical Trials
* Member Directory
* Membership Information * Funding Opportunities * Seminars & Lectures* Giving
* Giving & Impact
* Make a Gift
* Donor-Supported Research* Volunteer
* Community
* Community Overview * Health Disparities* Advocacy
* VICC Ambassadors
* Community Events
* Education
* Education, Training, and Career Development * Annual Scientific Retreat* Seminar Series
* Seminars & Lectures* About
* About Vanderbilt-Ingram* Leadership
* Fast Facts
* History
* Careers
* News Center
* For Media
* Event Calendar
* Momentum magazine
* More
* Intranet (for faculty and staff)* About the site
* Help
* Contact the web team COVID-19 ALERT FOR CANCER PATIENTS The Vanderbilt-Ingram Cancer Center is following the COVID-19 pandemic closely and taking steps to protect our patients and our staff. Please be assured that we are here for you. *UPDATED APRIL 6, 2020* COVID-19 Info For Cancer Patients We will be diligently updating information on a regular basis for specific diseases and conditions.
For cancer info, click here.
Para más información en Español sobre cáncer visite la siguientepágina
.
For the latest info about coronavirus for VUMC employees and patients.
For the latest VUMC restricted visitor policy.
PARTNERS IN DISCOVERY*
For Patients
*
Find a Clinical Trial*
Make A Gift
*
Join Our Team
Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead uscloser to a cure.
No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for thosewith cancer.
Harnessing the power of science for our patients OUR DOCTORS AND RESEARCHERS ARE TURNING TODAY'S scientific discoveries into tomorrow's treatments. Learn more about our research programs and initiatives.Research Programs
* Breast Cancer Research Program * Cancer Epidemiology Research Program * Cancer Health Outcomes & Control * Gastrointestinal Cancer Research Program * Genome Maintenance Research Program * Host-Tumor Interactions Research Program * Signal Transduction and Chemical Biology Research Program * Translational Research and Interventional Oncology ResearchProgram
Specialized Programs of Research Excellence (SPOREs) * SPORE in Breast Cancer * SPORE in Gastrointestinal Cancer Research Centers & Initiatives * Early Detection and Cancer Prevention * Health Disparities* Hereditary Cancer
* Meharry-Vanderbilt-Tennessee State Cancer Partnership * Shanghai Women's Health Study * Shanghai Men's Health Study * Southern Community Cohort StudyPROVEN TRACK RECORD
A leader in research, innovation and treatment. We are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach. ------------------------- PATIENTS, PARTNERS, PROGRESS Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care. Read their stories from _Momentum_magazine.
Blazing a new trail
Clinical trial participant forges a different treatment path We’ve Only Just Begun Facing cancer with youthful resiliencePay it Forward
Bladder cancer research fund honors mentorBlazing a new trail
Clinical trial participant forges a different treatment path We’ve Only Just Begun Facing cancer with youthful resilienceleft
right
CANCER CENTER NEWS
Latest news about our research, patient care programs, outreach andeducational events.
JOURNEY HOME PROJECT SUPPORTS FIRST CAR-T INFUSION AT VA HOSPITAL The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital inNashville.
Read More
ACMG ISSUES STATEMENT ON BREAST CANCER GENETIC TESTING According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.Read More
NCI ‘MOONSHOT’ GRANT TO BOOST HEREDITARY CANCER IDENTIFICATION VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.Read More
HIGH FIBER, YOGURT DIET ASSOCIATED WITH LOWER LUNG CANCER RISK A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study in _JAMA Oncology_.Read More
COLORECTAL CANCER RESEARCHERS RECEIVE SPORE FUNDING Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).Read More
GRANT STRENGTHENS BREAST CANCER RESEARCH EFFORTS Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of ResearchExcellence funding.
Read More
More News Stories
FEATURED EVENTS
VIEW ALL SEMINARS AND EVENTS ------------------------- This form needs Javascript to display, which your browser doesn't support. Sign up hereinstead
STAY INFORMED
Subscribe for latest news and event updates from Vanderbilt-IngramCancer Center
First name *
Last name *
Email *
* = required field
------------------------- HAVE ANY QUESTIONS? Contact Us 1-877-936-8422 for more informationCall Now
Connect With Us
Copyright © 2020 Vanderbilt University Medical Center. All rightsreserved.
Vanderbilt © and the Vanderbilt logos are registered trademarks of The Vanderbilt University.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0